The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors.EBI
Revolution Medicines
Biphenyl and Phenylpyridine CompoundsBDB
Pfizer
COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORSBDB
Universitat De Barcelona
SMALL MOLECULE INHIBITOR FOR CATHEPSIN C AND MEDICINAL USE THEREOFBDB
Reistone Biopharma Company
Methods of improving cell-based therapyBDB
University of California
MAGL inhibitorsBDB
H. Lundbeck
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsBDB
Janssen Pharmaceutica
Heterocyclic compounds as BET inhibitorsBDB
Nuvation Bio
Potent and selective inhibitors of monoamine transporters; method of making; and use thereofBDB
The Usa, As Represented By The Secretary, Dhhs
3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonistsBDB
Rugen Holdings (Cayman)
SHMT inhibitors and uses thereofBDB
Raze Therapeutics